PE/Cyanine7 anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PEslashCy7_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (top) or PE/Cyanine7 Armenian hamster IgG isotype control (bottom)
  • N418_A_PEslashCy7_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (top) or PE/Cyanine7 Armenian hamster IgG isotype control (bottom)
  • N418_B_PEslashCy7_Neg_071006
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
117317 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117318 100 µg 185€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

 


BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

 

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hennion-Tscheltzoff O, et al. 2013. Blood. 121:4684. PubMed
  2. Škrnjug I, et al. 2014. PLoS One. 9:95728. PubMed
  3. Suzuki T, et al. 2014. J Dermatol Sci. 74:116. PubMed
  4. Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
  5. Škrnjug I, et al. 2014. PLoS One. 9:110150. PubMed
  6. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  7. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  8. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  9. Stack G, et al. 2015. PLoS Pathog. 11:1004641. PubMed
  10. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  11. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  12. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  13. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  14. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  15. Colliou N, et al. 2015. Toxins. 7: 3805 - 3817. PubMed
  16. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  17. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  18. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  19. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  20. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  21. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  22. Velázquez F, et al. 2016. J Immunol. 196: 1305 - 1316. PubMed
  23. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  24. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  25. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  26. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  27. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  28. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  29. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  30. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  31. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  32. Ghosh D, et al. 2016. J Immunol. 197: 1788 - 1800. PubMed
  33. Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed
  34. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  35. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  36. Kolawole A, et al. 2015. J Virol. 90: 1499-1506. PubMed
  37. Yasuda T, et al. 2016. PLoS One. 11:e0167952. PubMed
  38. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  39. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  40. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  41. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  42. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  43. Crosse EI, et al. 2020. Cell Stem Cell. 27:822. PubMed
  44. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  45. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  46. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  47. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  48. Reimer E, et al. 2020. J Cell Sci. 134:00:00. PubMed
  49. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  50. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  51. Ndoja A, et al. 2020. Cell. 182(5):1156-1169.e12. PubMed
  52. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  53. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  54. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  55. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  56. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  57. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  58. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  59. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  60. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  61. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  62. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  63. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  64. Dong L, et al. 2021. Cancer Cell. . PubMed
  65. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  66. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  67. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  68. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  69. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  70. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  71. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  72. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  73. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  74. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  75. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  76. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  77. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  78. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  79. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  80. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  81. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  82. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  83. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  84. Thwe PM et al. 2017. Cell metabolism. 26(3):558-567 . PubMed
  85. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  86. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  87. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  88. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  89. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  90. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  91. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  92. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  93. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  94. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  95. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  96. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  97. Christ A, et al. 2018. Cell. 172:162. PubMed
  98. Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed
  99. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  100. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  101. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  102. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  103. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  104. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  105. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  106. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  107. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  108. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  109. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  110. Schuh E, et al. 2017. J Immunol. 198:3081. PubMed
  111. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  112. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  113. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  114. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  115. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  116. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  117. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  118. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  119. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  120. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  121. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  122. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  123. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  124. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  125. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  126. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  127. Kim M, et al. 2018. Immunity. 49:151. PubMed
  128. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  129. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  130. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  131. Baudoux T, et al. 2018. Sci Rep. 4.0375. PubMed
  132. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  133. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  134. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  135. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  136. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  137. Al–Rashed F, et al. 2020. Sci Rep. 10:16802. PubMed
RRID
AB_493569 (BioLegend Cat. No. 117317)
AB_493568 (BioLegend Cat. No. 117318)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC, IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC, CyTOF®, IP, IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC, IHC, ICC, 3D IHC, SB
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC, IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F, 3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account